| Value | ₹156.0 Cr |
|---|---|
| Execution period | On or before December 5, 2026 |
BSE filing, NSE: ETERNAL. Summary written from the filing by ALFA Finder's alert engine.
Eternal Ltd: key numbers
- Share price
- ₹337.85
- Market cap
- ₹3,26,037 Cr
- Revenue (annual)
- ₹54,364 Cr
- Net profit (annual)
- ₹366.0 Cr
- P/E (TTM)
- 661.3×Sector 60.2×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 33.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eternal Ltd
All →Eternal Earnings Call Transcript: Key Takeaways
Q2FY27 call disclosed no financial figures. Management held food margins flattish for 1–2 years, reinvested in quick commerce expansion, maintained the $1B FY29 Adjusted EBITDA guide, and declined to quantify key metrics.
Eternal Merger & Restructuring Worth ₹130.8 Cr
Eternal Limited sold its India going-out business to subsidiary ZEPL for ₹130.76 Crore. The board-approved slump sale is a related-party transaction at arm's length.
- Value
- ₹130.8 Cr
- Execution
- Expected completion by 20-Nov-2026
Eternal Other Announcement
Eternal Limited submitted its Monitoring Agency Report for the quarter ended September 30, 2026, confirming that the QIP proceeds utilization aligns with the original objects.
Eternal Business Update
Eternal Ltd filed a Q2FY27 shareholders' letter under Reg 30, containing the CEO's strategy Q&A on a new AI product (dark.ai) and non-GAAP headline metrics.
Eternal Q2 FY27 Results: Net Profit ₹125 Cr, Up 92.3% YoY
Eternal Ltd reported revenue from operations of ₹24,138 Cr (+77.6% YoY) and net profit of ₹125 Cr (+92.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹125 Cr · +92.3% YoY
Eternal Board Meeting Date
Eternal Limited will hold a board meeting on October 21, 2026, to approve the financial results for the quarter and half-year ended September 30, 2026.
Other acquisition announcements
All →Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr
Meesho Acquisition Worth ₹50 Cr
Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.
- Value
- ₹50.00 Cr
- Execution
- Within 1 year from the closing of the first tranche of the original acquisition
Meesho Acquisition Worth ₹18.74 Cr
Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.
- Value
- ₹18.74 Cr
Meesho Acquisition Worth ₹6.17 Cr
Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.
- Value
- ₹6.17 Cr
Skyways Air Services Acquisition Worth ₹3.13 Cr
Skyways Air Services will invest Rs.3.13 Crore in cash for additional equity in UAE subsidiary Skyways SLS Cargo Services LLC. The investment funds working capital needs.
- Value
- ₹3.13 Cr
- Execution
- Indicative completion within 30 days